AGP Picks
View all

AGP Executive Report

Your go-to archive of top headlines, summarized for quick and easy reading.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

Research Access: India has concluded negotiations to join the EU’s Horizon Europe programme, opening funding calls and research infrastructure to Indian institutions and companies. AI in Health: The UK is investing more than $120 million with partners in five AI research hubs designed to detect serious illnesses earlier, including projects using wearable sensors. Autism Genetics: Researchers identified hundreds of previously overlooked gene segments linked to autism and other neurological conditions, and developed a machine-learning method to assess the effects of genetic variants. Startup Innovation: India has connected its Startup India Portal with I-STEM, helping recognised startups find research, testing and prototyping facilities at academic institutions. Cancer Drugs: Samsung Bioepis has presented Phase 3 results for its proposed Keytruda biosimilar, reporting comparable performance in a 555-patient lung cancer trial as its US application enters FDA review.

Biosecurity: The White House will require screening of synthetic DNA orders and synthesis equipment, aiming to prevent misuse while supporting biotechnology research. Gene Therapy Safety: Novartis reported nine tumor cases among patients treated with Zolgensma; two showed evidence the delivery virus had integrated into patients’ DNA. The company says it notified regulators, but the reports do not establish that the therapy caused the tumors. Nuclear Energy: Idaho National Laboratory researchers are testing whether molten-salt reactor fuel can be reused, potentially reducing the U.S. stockpile of spent nuclear fuel. AI in Research: A Harvard-led team received nearly $7 million to develop AI “co-scientists” that generate hypotheses and suggest experiments for cancer studies, with researchers retaining scientific oversight. Medical Testing: University of Illinois researchers demonstrated a portable method for detecting Zika and hepatitis C RNA in whole blood, without lab-grade equipment or sample purification. HIV Prevention: Gilead reported that 85.6% of trial participants receiving twice-yearly lenacapavir remained on schedule at one year, compared with 46.3% taking daily oral PrEP; no HIV infections occurred in the injectable group during the study.

Quantum Computing: IBM, Oak Ridge National Laboratory and AMD launched a platform combining a 120-qubit quantum processor with high-performance computing to advance error correction. Space Communications: Sceye and SoftBank signed a five-year deal to deploy stratospheric platforms over Japan for broadband, disaster communications and future network services. Biomanufacturing: MRM Health and Biocodex plan a €15 million French facility to scale production of microbiome-based medicines. Space Physics: Chinese researchers cooled rubidium atoms to a record 9.7 picokelvin aboard the space station, holding the temperature for seven seconds. Robotics: South Korea opened its first dedicated humanoid-robot data factory, where operators record robots performing household and industrial tasks. Undersea Security: Estonia’s Elering will use passive acoustic sensors to monitor Baltic Sea power cables for threats including sabotage and anchor damage.

Neurotechnology: Surgeons have implanted a wireless brain device for a third time, testing whether it can provide artificial vision for people with total blindness. AI in Medicine: An RPI team’s AI model analyzes health questionnaires to flag possible Parkinson’s disease earlier; it is designed for screening, not diagnosis. Research Tools: UT Southwestern researchers developed a versatile microscope for 3D imaging of cells and tissues, while WashU-led studies compared methods for measuring DNA changes linked to aging and cancer. Critical Materials: The U.S. Department of Energy is backing projects to extract rare earths from industrial waste, including a planned Louisiana facility designed to produce up to 1,000 metric tons a year. Energy Storage: GridPoint aims to deploy 2 gigawatts of battery storage across more than 20,000 commercial sites as electricity demand rises. Regenerative Medicine: A $6.9 million grant will support preclinical work on a stem-cell therapy intended to repair heart muscle after severe heart attacks, with human trials targeted for late 2027.

Asthma Therapy: Ethris reported that its nasal mRNA candidate cut rhinovirus levels 40-fold versus placebo at the second-day peak in a Phase 2a trial involving adults with asthma; it was well tolerated. PFAS Cleanup: University of Utah researchers are testing a way to break down PFAS at temperatures mostly below 110°C, far below the roughly 1,000°C used by many existing methods. Autonomous Industry: Einride and Lorenz have deployed four self-driving electric vehicles to move goods around a German factory, replacing diesel-powered transport. Space Research: Israel and Kazakhstan agreed to explore joint satellite, Earth-observation and research projects. AI and Biology: The UK’s new AI Biosecurity Lab will use AI to support research and medicine discovery while working to prevent its misuse in developing biological weapons. Molecular Materials: Researchers in Japan developed a method to build nanographenes with as many as eight helicene units, offering tunable optical properties for future optoelectronic devices.

Antarctic Connectivity: A feasibility study found a submarine fibre-optic cable linking Chile to Antarctica is technically viable, potentially giving research stations faster, more reliable access to global networks than satellite links. Research and Academic Freedom: A federal judge dismissed all charges against Harvard researcher Kseniia Petrova, accused of bringing frog embryos into the U.S. for cancer research. Tuberculosis Research: Rockefeller scientists mapped thousands of genetic interactions in the TB bacterium, revealing possible targets for new drugs and antibiotic combinations. AI Devices: Nothing CEO Carl Pei says the company will launch a screen-free AI product next month, though he has not disclosed what it does. Biomedicine: Researchers report that a targeted nanoimmunotherapy reduced atherosclerotic plaque in mice, while a separate genetic study links a variant to rare liver injury from blood-pressure drugs. Industrial R&D: Unilever is investing €35 million in its Indian research centres to expand product science, prototyping, advanced manufacturing and AI tools.

AI and Robotics: South Korea opened its first humanoid-robot data factory, where 12 remotely operated machines collect task data to train robots for autonomous work. Chips and Computing: South Korea and AMD began coordinating plans for AI computing infrastructure, research and workforce training, while STMicroelectronics unveiled new microcontrollers for AI data centres and robotics. Next-Generation Batteries: South Korean researchers developed a transfer-printing method for making thin, uniform solid-electrolyte layers, a potential step toward manufacturing solid-state batteries at scale. Biomedicine: Scientists reported rewriting human DNA inside the body for the first time; separate research identified a possible link between a gut bacterium and colon cancer. Space: NASA is seeking commercial proposals to service the Hubble Space Telescope as concerns grow about its future.

AI Model Editing: MIT researchers say GPT-6 Astra boosted a smaller model’s math score by editing its weights; critics argue the result relies on established machine-learning methods. AI Infrastructure: Tower Semiconductor and Innolight are advancing optical links that could move data faster between chips in AI systems. Alzheimer’s Research: An international study of 2.8 million people identified 48 new genetic regions associated with the disease, pointing to immune cells and neurons as possible therapeutic targets. Health Diagnostics: Nagoya University researchers developed a blood- and urine-based method that may detect chronic inflammation and help pinpoint its source. Weather Forecasting: A Colorado-Wyoming team is using AI to improve hail forecasts, with the goal of extending warnings from minutes to hours or days. Fusion Energy: UC San Diego and OpenStar Technologies received a U.S. energy grant to study turbulence in a levitated-plasma fusion system. Biopharma: Lonza agreed to buy five U.S. manufacturing sites from Merck KGaA, adding about 1,100 employees; the deal is expected to close in 2027.

AI Governance: Hong Kong’s monetary authority has launched Project SAGE, a banking initiative to develop identity, permission and accountability standards for autonomous AI agents that can move money and act without step-by-step human approval. Smarter Power Grids: A Nordic research project backed by up to €13.3 million will use AI to improve the use and resilience of existing electricity networks as renewables and demand grow. Gene Editing: Penn researchers report that CRISPR-driven increases in utrophin improved muscle function in mice with Duchenne muscular dystrophy, pointing to a potential treatment approach that still needs further testing. Fusion Research: The U.S. Department of Energy has awarded $8.5 million to advance commercial fusion research. Quantum Computing: Japan has powered up a quantum computer built from single atoms, a development that could offer an alternative to systems requiring large, ultra-cold equipment.

Advanced Materials: Argonne scientists used real-time X-ray imaging and ultrasound to improve aluminum alloys, potentially enabling more recycled metal in vehicles and reducing reliance on newly produced materials. AI in Healthcare: A Stony Brook study found that an AI system could organize complex patient records into draft discharge summaries in minutes, offering a possible way to ease clinicians’ documentation burden. Cancer Research: UNC researchers uncovered a previously unrecognized role for immune protein cGAS in regulating cholesterol and tumor growth, pointing to new avenues for cancer treatment research. AI & RNA: A new $15 million Department of Energy award will support using AI to decode RNA structures, a difficult task that could aid scientific discovery. Drought Forecasting: Researchers at IIT Bombay are combining satellite data and AI to forecast droughts up to four weeks ahead. Genetic Engineering: Scientists report rewriting human DNA inside the body for the first time, a milestone that could open new research directions for gene-based treatments. Quantum Computing: A Florida Atlantic University team tested quantum machine-learning methods for lung cancer prediction using limited data, but the findings remain an evaluation of potential rather than a clinical tool.

Global Science Partnerships: Oman and China signed 14 cooperation agreements covering AI, space science, digital economies and supply chains, while Indonesia is asking universities to help build a national chip-design ecosystem. Computing & Chips: South Korea launched a supercomputer billed as 24 times faster than its predecessor and is exploring a quantum link. Researchers also developed a nitrogen-powered semiconductor chiller that reaches −120°C without contributing to global warming. AI & Medicine: Pfizer is partnering with Edison Scientific to accelerate AI-driven drug research, as Anthropic expands its work on drug discovery. Separately, scientists report rewriting human DNA inside the body for the first time; another team has put an AI-designed virus into a human, raising new questions about oversight. Space: NASA is turning to commercial companies for help keeping the Hubble Space Telescope in orbit.

Space Weather: A 2024 solar storm pushed high-energy electrons through a boundary once thought impassable, raising concerns about radiation risks to satellites. Genetic Medicine: Researchers report rewriting human DNA inside the body for the first time, a step that could expand gene therapy but will require careful safety testing. AI and Energy: A Sierra Club analysis warns planned U.S. data centers could drive emissions sharply higher by 2030, undoing years of reductions as developers turn to fossil-fuel power. Heart Care: A 1,105-patient trial found CT-guided planning for coronary procedures matched IVUS outcomes at one year, with shorter procedures and less contrast. Digital Senses: Researchers demonstrated a system that detects odors in one location and recreates corresponding scents elsewhere, with early tests spanning coffee, citrus and wine.

In-Body Gene Editing: Prime Medicine has treated its first Wilson’s disease patient with prime editing delivered directly into the body. The trial will test whether it can safely correct the faulty gene; initial results are expected in 2027. New Treatments: The FDA granted accelerated approval to Voceryq, the first plasmid DNA immunotherapy, for recurrent respiratory papillomatosis. Separately, a trial of nasal-spray mebufotenin found reduced depression symptoms lasting through eight weeks. AI Drug Discovery: Parse Biosciences and Nomic Bio plan a 100-million-cell dataset linking immune-cell gene activity to proteins released by cells, with major drugmakers among the partners. Semiconductors: India’s chip ambitions face a supply-chain gap: the country still imports most semiconductor-grade materials, chemicals, equipment and critical minerals, industry experts say. Planetary Science: A decade of Juno observations has exposed a mismatch between Jupiter’s measured interior and the Galileo probe’s atmospheric readings, challenging how scientists study giant planets.

Bioengineering: Binghamton researchers modeled a battery on the small intestine’s villi, producing more than eight times the electricity per volume of a flat microbial fuel cell. Cancer Research: Johns Hopkins scientists identified claudin-4 as the docking point a gut-bacterial toxin uses to attack colon cells; a molecular decoy protected mice, pointing to a possible prevention strategy. Climate Science: A study of Canada’s Barnes ice cap suggests human-driven warming halted ice growth that had been underway for about 2,000 years. Space: NASA’s Swift telescope is expected to re-enter Earth’s atmosphere after a $30 million orbit-raising rescue failed. Separately, NASA is looking to commercial companies for ideas to extend the Hubble telescope’s life. Space Technology: ISRO launched the GSLV-F18 carrying navigation satellite NVS-03. Biodiversity: Countries at COP17 completed a global review and warned that efforts to reverse nature loss by 2030 need to accelerate.

AI and Data: India has proposed a framework to let researchers and companies train AI on data from hospitals, banks and public agencies, using secure environments and privacy safeguards. Finance and healthcare pilots are planned. Space: ISRO’s GSLV-F18 rocket placed the NVS-03 navigation satellite in orbit, strengthening India’s NavIC system. Medical Research: The Indian Council of Medical Research has launched a four-year study of 200 families to investigate genetic factors behind rising autoimmune disease rates. Particle Physics: New results from oxygen-nucleus collisions at Brookhaven’s RHIC suggest quark-gluon plasma—the matter present shortly after the Big Bang—can form at lower energies than previously established. Drug Discovery: Researchers have used light to build a new generation of drug molecules, pointing to a potential route for more precise pharmaceutical chemistry.

AI & Copyright: Anthropic has updated Claude Code to refuse requests to recreate specific existing games, amid indie developers’ concerns that AI could speed up copycat releases. Space & Navigation: ISRO launched NVS-03 to strengthen NavIC, India’s homegrown satellite navigation system. Semiconductors: Indiana University has partnered with chip research center imec, while Draper has broken ground on a Lowell microelectronics center planned to open in 2029. Research Funding: Four Argonne researchers will each receive $550,000 annually for five years to pursue projects in X-ray optics, chemical reactions, materials and climate science. Health Science: Mayo Clinic’s Precure initiative combines medical, genetic, wearable and environmental data to study disease before symptoms appear. Drug Policy: A new study suggests existing drug laws can shape public views of substances, keeping attitudes out of step with expert assessments of harm.

Diagnostics: Roche won CE Mark approval for a compact immunoanalyser designed to bring central-lab testing to smaller clinics, and launched a test to help distinguish mesothelioma from other cancers. AI in Medicine: A California startup says it used AI to design a bacteriophage and administered it to a patient with a serious bacterial infection; the reported outcome remains unclear, but the approach could offer a targeted alternative to antibiotics. Research Partnerships: Korea and Canada agreed to expand joint work in AI, biotechnology and quantum science. Separately, Edison Scientific will deploy its AI research platform across Pfizer’s drug-development pipeline. Clinical Adoption: South Korea has approved 549 AI medical devices, but only 49 are covered by national health insurance, highlighting reimbursement and data-access barriers to wider use. New Sensors: Researchers in Japan developed programmable nanovesicles that detect pressure through changes in fluorescence, offering a potential way to study microscopic environments in living tissue.

Gut Microbes: A study overturns a decades-old assumption: picobirnaviruses infect gut bacteria, not human cells, opening new questions about their role in health. AI and Drug Discovery: Researchers used AI to map cell-surface proteins and identified 1,108 potential drug targets missing from major databases. Biology: A first whole-body, single-cell atlas of an adult vertebrate maps more than 600,000 cells in a tiny transparent fish, offering a resource for studying tissues, aging and disease. Materials Science: AI searches of old research uncovered 33 overlooked MXene materials, while a faster, greener method could help bring them closer to use in clean technology. Health Policy: U.S. officials eased access to several unapproved compounded peptides despite safety concerns from FDA scientists.

AI Race: Google launched Gemini 4 Carbon, saying it leads a major benchmark and offers stronger coding and long-running task abilities; initial access is limited to cyber defenders and trusted partners. AI Costs: Alphabet’s $127.6 billion quarter missed Wall Street forecasts, while heavy AI investment drove free cash flow further into the red and renewed questions about returns. Biotech Manufacturing: Merck opened a $334 million plant in South Korea to make materials for biologic medicines, bringing production closer to drugmakers across Asia-Pacific. Fusion Energy: Japan’s Helical Fusion and Germany’s Gauss Fusion signed a statement of intent to advance commercial fusion, combining research and industrial expertise while pursuing separate technologies. Scientific Instruments: University of Nebraska researchers demonstrated a sensor that can distinguish multiple chemical reactions on one electrode, with potential applications in early disease detection and radiation-injury assessment. Water Technology: India launched a geospatial app to map groundwater recharge opportunities and help communities choose structures suited to local conditions.

Cancer Research: UCSF scientists engineered CAR-T cells that activate inside the brain and cleared lethal childhood tumors in mice; clinical trials could begin in 2027. Gene Therapy: The FDA proposed a “plug-and-play” pathway for personalized treatments, allowing some therapies targeting additional mutations to rely on lab data rather than new clinical trials. Researchers also reported editing human DNA inside the body for the first time. Quantum Computing: German startup NVision says it has built a manufacturable molecular qubit, with the advance validated in a peer-reviewed Nature paper. Climate Science: A study found Antarctic sea-ice loss has more than doubled the reduction in freshwater entering the global oceans, with potential consequences for ocean circulation.

Sign up for:

Technology News Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Technology News Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.